Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
Go back to Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone| (NASDAQ: APVO) | Delayed: 1.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.81 | 52 Week High | $4.33 | |||
| Open | $1.81 | 52 Week Low | $1.80 | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.81 | EPS | $0.00 | |||
| Volume | 1,377 | |||||
